Cystic Fibrosis Lung Transplant Recipients Have Suppressed Airway Interferon Responses during Pseudomonas Infection
Daniel T. Dugger(University of California, San Francisco), John R. Greenland(University of California, San Francisco), Lorna Zlock, Steven R. Hays(University of California, San Francisco), Erin Gordon(University of California, San Francisco), Louis Z. Sharp(University of California, San Francisco), Jonathan P. Singer(University of California, San Francisco), Walter E. Finkbeiner, Monica Fung(University of California, San Francisco), Lorriana E. Leard(University of California, San Francisco), Jasleen Kukreja(University of California, San Francisco), Mary Ellen Kleinhenz(University of California, San Francisco), Rupal Shah(California University of Pennsylvania), Saharai Caldera(University of California, San Francisco), Chaz Langelier(Chan Zuckerberg Initiative (United States))
Cited by 18
Related Papers
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Human BAT Possesses Molecular Signatures That Resemble Beige/Brite Cells
|PLoS ONE|2012|637
COVID-19 in Immunocompromised Hosts: What We Know So Far
|Clinical Infectious Diseases|2020|568
Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults
|Proceedings of the National Academy of Sciences|2018|434
Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction
|Proceedings of the National Academy of Sciences|2012|345